These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4403862)

  • 1. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 2. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Imamura H; Nakamura T; Kimura T
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
    Proctor JD; Allen FJ; Wasserman AJ
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
    Washizu Y
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-arrhythmic, antianginal and cardiovascular effects of the beta receptor blocking agent TE-176 (Chinoin-103)].
    József S; János S; Judit S; Kálmán H; Dezsŏ K
    Acta Pharm Hung; 1977 Sep; 47(5):227-40. PubMed ID: 21516
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic effects of oxprenolol and practolol in dogs under halothane anaesthesia.
    Strong AJ; Macnicol MF; Davie IT; Scott DB
    Br J Anaesth; 1971 Jan; 43(1):25-32. PubMed ID: 4396678
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
    Imamura H; Nakamura T; Inui J; Yasuda H; Osuga K
    Yakugaku Zasshi; 1972 Aug; 92(8):1039-51. PubMed ID: 4404839
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phenbutolol (Hoe 893d), a new highly efficient -sympatholytic agent with long action duration].
    Härtfelder G; Lessenich H; Schmitt K
    Arzneimittelforschung; 1972 May; 22(5):930-2. PubMed ID: 4403127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.